20+ Years of Evidence

Join the experts’ corner

This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.

Featured Content

RSS Scientific Meeting

Stereotactic Radiosurgery for the Treatment of Uveal Melanoma: An Eighteen-Year Single Institution Experience

Date: 2023
Treatment Technique: SRS
Platform: CyberKnife
Author: Felix Ehret et al.

Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results

Date: 2023
Treatment Technique: SBRT
Platform: CyberKnife
Author: Christopher Mendez et al.

RSS Scientific Meeting

Organ-Preservation with Concurrent Immunotherapy and Radiotherapy in Bladder Cancer

Date: 2023
Treatment Technique: IG-IMRT
Platform: TomoTherapy
Author: Imanol Paguey Garrido et al.
  • Products

  • Techniques

  • Types

  • Indications

  • Event

  • Formats

PO-1246: Lung SBRT after pneumonectomy

Angela Botticella, Antonin Levy, Olaf Mercier, Guillaume Auzac, Aicha Traore-Diallo, Maxime Frelaut, Pauline Pradere, Caroline Caramella, Ines Kasraoui, Benjamin Besse, David Planchard, Cécile Le Pechoux | ESTRO | 2022

Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique

Maria Alessia Zerella, Samantha Dicuonzo, Samuele Frassoni, Mattia Zaffaroni, Marianna Alessandra Gerardi, Anna Morra, Damaris Patricia Rojas, Simona Arculeo, Luca Bergamaschi, Cristiana Fodor, Francesca Emiro, Consiglia Piccolo, Vincenzo Bagnardi, Federica Cattani, Viviana Galimberti, Paolo Veronesi, Roberto Orecchia, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa | J Cancer Res Clin Oncol | 2022